Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07470177 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Investigate the Effects of JMKX003142 on QTc Interval in Healthy Adults

StatusNot Yet Recruiting
PhasePhase 1
SponsorJemincare
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 13, 2026 (before its estimated May 14, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Jemincare
23 trials monitored
See all monitored trials
The primary objective of this study is to assess the effect of a therapeutic and supratherapeutic oral dose of JMKX003142 on the corrected cardiac QT interval relative to a placebo in healthy participants
Trial Details
NCT Number NCT07470177
Lead Sponsor Jemincare
Collaborators: Zhejiang Hangyu Pharmaceutical Co., Ltd.
Conditions
(from sponsor)		 ADPKD (Autosomal Dominant Polycystic Kidney Disease)
Related terms Polycystic Kidney, Autosomal Dominant
Enrollment 24 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov